| Year |
Citation |
Score |
| 2003 |
Knapp DC, Mata JE, Reddy MT, Devi GR, Iversen PL. Resistance to chemotherapeutic drugs overcome by c-Myc inhibition in a Lewis lung carcinoma murine model. Anti-Cancer Drugs. 14: 39-47. PMID 12544257 DOI: 10.1097/00001813-200301000-00006 |
0.531 |
|
| 2002 |
Ricker JL, Mata JE, Iversen PL, Gattone VH. c-myc antisense oligonucleotide treatment ameliorates murine ARPKD. Kidney International. 61: S125-31. PMID 11841626 DOI: 10.1046/J.1523-1755.2002.0610S1125.X |
0.484 |
|
| 2000 |
Mata JE, Bishop MR, Tarantolo SR, Angel CR, Swanson SA, Iversen PL. Evidence of enhanced iron excretion during systemic phosphorothioate oligodeoxynucleotide treatment. Journal of Toxicology. Clinical Toxicology. 38: 383-7. PMID 10930054 DOI: 10.1081/Clt-100100947 |
0.458 |
|
| 2000 |
Mata JE, Jackson JD, Joshi SS, Tracewell WG, Pirruccello SJ, Murphy BJ, Bishop MR, Iversen PL. Pharmacokinetics and in vivo effects of a six-base phosphorothioate oligodeoxynucleotide with anticancer and hematopoietic activities in swine. Journal of Hematotherapy & Stem Cell Research. 9: 205-14. PMID 10813533 DOI: 10.1089/152581600319414 |
0.527 |
|
| 1999 |
Iversen PL, Cornish KG, Iversen LJ, Mata JE, Bylund DB. Bolus intravenous injection of phosphorothioate oligonucleotides causes hypotension by acting as alpha(1)-adrenergic receptor antagonists. Toxicology and Applied Pharmacology. 160: 289-96. PMID 10544063 DOI: 10.1006/Taap.1999.8771 |
0.501 |
|
| 1999 |
Page TJ, Mata JE, Bridge JA, Siebler JC, Neff JR, Iversen PL. The cytotoxic effects of single-stranded telomere mimics on OMA-BL1 cells. Experimental Cell Research. 252: 41-9. PMID 10502398 DOI: 10.1006/Excr.1999.4613 |
0.537 |
|
| 1997 |
Takeda A, Hisada H, Okada S, Mata JE, Ebadi M, Iversen PL. Tumor cell growth is inhibited by suppressing metallothionein-I synthesis. Cancer Letters. 116: 145-9. PMID 9215857 DOI: 10.1016/S0304-3835(97)00172-9 |
0.517 |
|
| 1997 |
Mata JE, Joshi SS, Palen B, Pirruccello SJ, Jackson JD, Elias N, Page TJ, Medlin KL, Iversen PL. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicology and Applied Pharmacology. 144: 189-97. PMID 9169084 DOI: 10.1006/Taap.1997.8103 |
0.56 |
|
| 1995 |
Desjardins J, Mata J, Brown T, Graham D, Zon G, Iversen P. Cholesteryl-conjugated phosphorothioate oligodeoxynucleotides modulate CYP2B1 expression in vivo. Journal of Drug Targeting. 2: 477-485. PMID 7773609 DOI: 10.3109/10611869509015917 |
0.542 |
|
| 1995 |
Wang M, Mata J, Price CE, Iversen PL, Godfrey M. Prenatal and presymptomatic diagnosis of the Marfan syndrome using fluorescence PCR and an automated sequencer. Prenatal Diagnosis. 15: 499-507. PMID 7659684 DOI: 10.1002/Pd.1970150602 |
0.469 |
|
| 1994 |
Iversen PL, Mata J, Tracewell WG, Zon G. Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against rev from human immunodeficiency virus type 1 in the adult male rat following single injections and continuous infusion Antisense Research and Development. 4: 43-52. PMID 8061515 DOI: 10.1089/Ard.1994.4.43 |
0.519 |
|
| 1992 |
Iversen PL, Mata JE, Ebadi M. Synthetic antisense oligonucleotide probes the essentiality of metallothionein gene. Biological Signals. 1: 293-9. PMID 1307930 DOI: 10.1159/000109334 |
0.542 |
|
| 1992 |
Chang N, Liu AY-, Song Y, Pang SF, Bourreau J-, Kitchener P, Kwan CY, Daniel EE, Sun B, Jin G, Iversen PL, Mata JE, Ebadi M. Contents Vol. 1, 1992 Neurosignals. 1. DOI: 10.1159/000109341 |
0.438 |
|
| 1992 |
Chang N, Liu AY-, Song Y, Pang SF, Bourreau J-, Kitchener P, Kwan CY, Daniel EE, Sun B, Jin G, Iversen PL, Mata JE, Ebadi M. Subject Index Vol. 1, 1992 Neurosignals. 1: 341-342. DOI: 10.1159/000109340 |
0.433 |
|
| Show low-probability matches. |